Concepedia

Katri S. Selander

KS

47

Publications

4.1K

Citations

34

H-Index

1983

Active since

Affiliations

University of Alabama at Birmingham(Current)

University of Oulu

Oulu University Hospital

Birmingham VA Medical Center

University of Turku

Katri S. Selander is an author at University of Alabama at Birmingham specializing in medicine, cell biology, and breast cancer.

ORCID

Top concepts

Publications per year

1983–2022

47

Publications

47

TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development

Juan Juan Yin, Katri S. Selander, John M. Chirgwin et al. · Journal of Clinical Investigation · 1999 · 975 citations · Full text

Transforming Growth Factor-β Stimulates Parathyroid Hormone-related Protein and Osteolytic Metastases via Smad and Mitogen-activated Protein Kinase Signaling Pathways

Sanna-Maria Käkönen, Katri S. Selander, John M. Chirgwin et al. · Journal of Biological Chemistry · 2002 · 275 citations · Full text

Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages.

Katri S. Selander, Jukka Mönkkönen, Eeva-Kaisa Karhukorpi et al. · Molecular Pharmacology · 1996 · 239 citations

Toll-Like Receptor 9 Agonists Promote Cellular Invasion by Increasing Matrix Metalloproteinase Activity

Melinda A. Merrell, Joanna Ilvesaro, Niko Lehtonen et al. · Molecular Cancer Research · 2006 · 218 citations

, , +20

LONG-TERM CONTROLLED TRIAL WITH DIPHOSPHONATE IN PATIENTS WITH OSTEOLYTIC BONE METASTASES

Inkeri Elomaa, Carl Blomqvist, Pentti Gröhn et al. · The Lancet · 1983 · 210 citations

, , +3

Rows per page

1–5 of 47